460 related articles for article (PubMed ID: 25279492)
1. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
2. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
3. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
[TBL] [Abstract][Full Text] [Related]
4. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
5. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
[TBL] [Abstract][Full Text] [Related]
6. Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a).
Nemati H; Khodarahmi R; Rahmani A; Ebrahimi A; Amani M; Eftekhari K
Cell Biochem Funct; 2013 Jan; 31(1):36-40. PubMed ID: 22753196
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis.
Kong Y; Zhang S; Su X; Peng D; Su Y
Postgrad Med; 2019 Aug; 131(6):405-412. PubMed ID: 31298974
[No Abstract] [Full Text] [Related]
8. Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
Abu El-Hamd M; Adam El Taieb M; Mahmoud AA; Mahmoud Samy O
J Dermatolog Treat; 2019 Sep; 30(6):545-548. PubMed ID: 30482111
[No Abstract] [Full Text] [Related]
9. Atherosclerosis, some serum inflammatory markers in psoriasis.
Alpsoy S; Akyuz A; Erfan G; Akkoyun DC; Topcu B; Guzel S; Kaya S; Kulac M
G Ital Dermatol Venereol; 2014 Apr; 149(2):167-75. PubMed ID: 24819636
[TBL] [Abstract][Full Text] [Related]
10. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of tissue levels of serine protease inhibitor (vaspin) in psoriasis vulgaris patients: a possible mechanism of narrowband ultraviolet B radiation.
Sayed KS; Said ER; Mohammed FN; Algorhary M; Rashed LA
Arch Dermatol Res; 2019 Oct; 311(8):637-641. PubMed ID: 31292731
[TBL] [Abstract][Full Text] [Related]
12. Soluble intercellular adhesion molecule-1 levels in patients with psoriasis.
Schopf RE; Naumann S; Rehder M; Morsches B
Br J Dermatol; 1993 Jan; 128(1):34-7. PubMed ID: 8094011
[TBL] [Abstract][Full Text] [Related]
13. Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report.
Asefi M; Vaisi-Raygani A; Khodarahmi R; Nemati H; Rahimi Z; Vaisi-Raygani H; Tavilani H; Pourmotabbed T
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1192-8. PubMed ID: 24118377
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular adhesion protein-1 in atopic eczema.
Madej A; Reich A; Orda A; Szepietowski JC
Int Arch Allergy Immunol; 2006; 139(2):114-21. PubMed ID: 16361866
[TBL] [Abstract][Full Text] [Related]
15. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
[TBL] [Abstract][Full Text] [Related]
16. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.
Kanelleas A; Liapi C; Katoulis A; Stavropoulos P; Avgerinou G; Georgala S; Economopoulos T; Stavrianeas NG; Katsambas A
Clin Exp Dermatol; 2011 Dec; 36(8):845-50. PubMed ID: 21790728
[TBL] [Abstract][Full Text] [Related]
18. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
Pei Q; Sang WF; Zhao XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 and IL 17 in Psoriasis: Reliability as prognostic markers for disease severity and responsiveness to treatment.
Khashaba SA; Attwa E; Said N; Ahmed S; Khattab F
Dermatol Ther; 2021 Jan; 34(1):e14606. PubMed ID: 33249724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]